USPTO Examiner KEOGH MATTHEW R - Art Unit 1663

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18426520INSECTICIDAL POLYPEPTIDES AND USES THEREOFJanuary 2024February 2025Abandon1310NoNo
18409591ENZYMES AND METHODS FOR PRODUCING OMEGA-3 FATTY ACIDSJanuary 2024September 2024Allow820YesNo
18409596ENZYMES AND METHODS FOR PRODUCING OMEGA-3 FATTY ACIDSJanuary 2024September 2024Allow820YesNo
18409598ENZYMES AND METHODS FOR PRODUCING OMEGA-3 FATTY ACIDSJanuary 2024June 2025Abandon1820NoNo
18407908Induction method for improving yield and fertility of 2n pollen in Camellia oleiferaJanuary 2024September 2024Allow810NoNo
18407953METHODS FOR IMPROVING TRAITS IN PLANTSJanuary 2024December 2024Allow1110NoNo
18407975METHODS FOR IMPROVING TRAITS IN PLANTSJanuary 2024February 2025Allow1320YesNo
18488245INSECTICIDAL PROTEINS AND METHODS FOR THEIR USEOctober 2023September 2024Allow1110NoNo
18481358INIR11 TRANSGENIC MAIZE WITH JUNCTION SEQUENCE DELETIONSOctober 2023May 2025Allow1911NoNo
18481023INIR20 TRANSGENIC SOYBEAN WITH JUNCTION POLYNUCLEOTIDE DELETIONSOctober 2023January 2025Allow1611NoNo
18480794SOYBEAN VARIETY 01083648October 2023November 2024Abandon1410NoNo
18459484METHODS AND COMPOSITIONS FOR GENERATING COMPLEX TRAIT LOCISeptember 2023July 2024Allow1010NoNo
18355489MUSTARD GREEN PLANTS NAMED �PWRG-1�, �PWRG-2,� and �PWSGC�July 2023October 2024Allow1531YesNo
18331207SOYBEAN VARIETY CW1510074June 2023February 2025Allow2030NoNo
18142048SOYBEAN VARIETY EE1761104May 2023December 2024Allow1920NoNo
18118283METHODS FOR IMPROVING TRAITS IN PLANTSMarch 2023March 2024Allow1320YesNo
18179023Methods for improved plant gene-editingMarch 2023May 2024Allow1411NoNo
18167266SOYBEAN VARIETY 5PKFJ52February 2023June 2025Allow2910NoNo
17994367Plants and Seeds of Hybrid Corn Variety CH010362November 2022June 2025Allow3010NoNo
18058073MODIFIED EXCISABLE MON89034 TRANSGENIC MAIZE INSECT RESISTANCE LOCUSNovember 2022September 2023Allow1011NoNo
18058156MODIFIED EXCISABLE MON87701 SOYBEAN TRANSGENIC INSECT RESISTANCE LOCUSNovember 2022September 2023Allow1011NoNo
17991738Plants and Seeds of Corn Variety CV880075November 2022January 2025Allow2610NoNo
17984495VARIETY CORN LINE ZECI6164November 2022January 2025Allow2610NoNo
17981678VARIETY CORN LINE MFF6771November 2022January 2025Allow2610NoNo
17978665SOYBEAN VARIETY 01091599November 2022January 2025Allow2700NoNo
17956323SOYBEAN CULTIVAR 12340609September 2022January 2025Allow2810NoNo
17934916INSECTICIDAL PROTEINS AND METHODS FOR THEIR USESeptember 2022August 2024Allow2221NoNo
17949794SOYBEAN CULTIVAR 18071201September 2022May 2025Allow3210NoNo
17949759SOYBEAN CULTIVAR 11251200September 2022April 2025Allow3110NoNo
17949782SOYBEAN CULTIVAR 15202010September 2022May 2025Allow3210NoNo
17948581LETTUCE VARIETY NUN 08224 LTLSeptember 2022March 2025Allow3010NoNo
17946259SOYBEAN CULTIVAR 13250405September 2022January 2025Allow2810NoNo
17946819LETTUCE VARIETY NUN 09187 LTLSeptember 2022April 2025Allow3110NoNo
17943807SOYBEAN CULTIVAR 12140836September 2022January 2025Allow2810NoNo
17931210INSECTICIDAL POLYPEPTIDES AND USES THEREOFSeptember 2022July 2023Allow1000NoNo
17941753SOYBEAN CULTIVAR 18040716September 2022January 2025Allow2810NoNo
17941720SOYBEAN CULTIVAR 10330716September 2022November 2024Allow2610NoNo
17941734SOYBEAN CULTIVAR 16120716September 2022November 2024Allow2610NoNo
17941980SOYBEAN CULTIVAR 12050527September 2022November 2024Allow2610NoNo
17941671SOYBEAN CULTIVAR 15110716September 2022November 2024Allow2610NoNo
17941865SOYBEAN CULTIVAR 15450218September 2022November 2024Allow2610NoNo
17939792SOYBEAN CULTIVAR 11050124September 2022November 2024Allow2610NoNo
17905518PLANT HAVING ENHANCED RESISTANCE AGAINST COLORADO POTATO BEETLE AND METHOD FOR PRODUCING SAME, AND METHOD FOR EVALUATING RESISTANCE AGAINST COLORADO POTATO BEETLE IN PLANTSeptember 2022June 2025Allow3321YesNo
17893245ISOLATED POLYPEPTIDES AND POLYNUCLEOTIDES USEFUL FOR INCREASING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, YIELD AND BIOMASS IN PLANTSAugust 2022November 2023Abandon1510NoNo
17820912METHOD FOR BASE EDITING IN PLANTSAugust 2022April 2025Abandon3221NoNo
17871709HYBRID PEPPER PLANT NAMED ALTAMURAJuly 2022April 2025Allow3210YesNo
17808781MAIZE HYBRID X08V941June 2022December 2024Allow3010NoNo
17808811MAIZE HYBRID X08V966June 2022December 2024Allow3010NoNo
17808607MAIZE HYBRID X13R128June 2022December 2024Allow3010NoNo
17808837MAIZE HYBRID X08V911June 2022December 2024Allow3010NoNo
17808815MAIZE HYBRID X18V354June 2022December 2024Allow3010NoNo
17807403MAIZE INBRED 1PAKH79June 2022October 2024Allow2810YesNo
17807404MAIZE INBRED 1PGGG27June 2022October 2024Allow2810YesNo
17804176Cannabis plant named 'HBA-2'May 2022September 2024Abandon2810NoNo
17733123CREATION OF HERBICIDE RESISTANT GENE AND USE THEREOFApril 2022August 2024Allow2841YesNo
17730343INBRED CORN LINE KW4ER1723April 2022December 2024Abandon3210NoNo
17717357USE OF MORPHOGENIC FACTORS FOR THE IMPROVEMENT OF GENE EDITINGApril 2022March 2025Allow3521YesNo
17699260METHODS AND COMPOSITIONS FOR GENERATING COMPLEX TRAIT LOCIMarch 2022June 2023Allow1410NoNo
17686992SOYBEAN CULTIVAR 10632503March 2022December 2024Abandon3410NoNo
17803149Genes and uses for plant enhancementMarch 2022July 2024Abandon2821NoNo
17753315RNA-GUIDED NUCLEASES AND DNA BINDING PROTEINSFebruary 2022September 2024Allow3111YesNo
17680548Garden Bean Variety ThompsonFebruary 2022May 2025Allow3920NoNo
17670651CHIMERIC INSECTICIDAL PROTEINSFebruary 2022June 2023Allow1610NoNo
17578620COMPOSITIONS AND METHODS FOR CONTROLLING PLANT PESTSJanuary 2022February 2023Allow1300YesNo
17561410COTTON VARIETY 20R816B3TXFDecember 2021April 2025Allow3910NoNo
17555737Canola Hybrid Variety 9CN0103December 2021October 2024Abandon3410NoNo
17644157INIR6 TRANSGENIC MAIZEDecember 2021December 2024Allow3611YesNo
17547873Soybean Variety 103324628December 2021January 2025Allow3720NoNo
17643509SORGHUM INBRED 2PZJD13ADecember 2021October 2024Allow3420YesNo
17643514SORGHUM INBRED PH2934FRDecember 2021October 2024Allow3420YesNo
17643510SORGHUM INBRED PH2015FWDecember 2021October 2024Allow3420YesNo
17543763MALE STERILE CROP MUTATED ON TY-5 GENEDecember 2021August 2023Allow2020YesNo
17543811COMPOSITIONS AND METHODS FOR ALTERING FLOWERING AND PLANT ARCHITECTURE TO IMPROVE YIELD POTENTIALDecember 2021April 2025Abandon4141NoNo
17457322INSECTICIDAL PROTEINS AND METHODS FOR THEIR USEDecember 2021July 2023Allow2011YesNo
17531898Plants and Seeds of Corn Variety CV525601November 2021February 2024Allow2610NoNo
17529156Plants and Seeds of Hybrid Corn Variety CH011200November 2021January 2024Allow2610NoNo
17528558Plants and Seeds of Hybrid Corn Variety CH011190November 2021January 2024Allow2610NoNo
17524556Plants and Seeds of Hybrid Corn Variety CH011217November 2021December 2023Allow2610NoNo
17524530Plants and Seeds of Hybrid Corn Variety CH011212November 2021January 2024Allow2610NoNo
17524504Plants and Seeds of Hybrid Corn Variety CH011213November 2021January 2024Allow2610NoNo
17523797Plants and Seeds of Corn Variety CV399111November 2021February 2024Allow2710NoNo
17518824Plants and Seeds of Corn Variety CV521044November 2021January 2024Allow2710NoNo
17517379Plants and Seeds of Corn Variety CV512858November 2021March 2024Allow2910NoNo
17517029Plants and Seeds of Corn Variety CV526813November 2021March 2024Allow2910NoNo
17513515Plants and Seeds of Hybrid Corn Variety CH011002October 2021March 2024Allow2910NoNo
17513572PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010999October 2021March 2024Allow2910NoNo
17452111MAIZE HYBRID X08T848October 2021March 2024Allow2910NoNo
17451894MAIZE HYBRID X80P537October 2021January 2024Allow2710NoNo
17500196OPTIMAL MAIZE LOCIOctober 2021February 2024Allow2811NoNo
17499774INDUCIBLE EXPRESSION OF GENES IN ALGAEOctober 2021January 2024Abandon2711NoNo
17495940SOYBEAN CULTIVAR 03220926October 2021October 2023Allow2410NoNo
17495341SOYBEAN CULTIVAR 09020446October 2021May 2023Allow2000NoNo
17490581SOYBEAN VARIETY 01091744September 2021November 2023Abandon2610NoNo
17490601SOYBEAN VARIETY 01091756September 2021January 2024Abandon2710NoNo
17489005SOYBEAN VARIETY 01091705September 2021September 2023Allow2310NoNo
17488951SOYBEAN VARIETY 01091695September 2021November 2023Abandon2610NoNo
17488805SOYBEAN VARIETY 01091605September 2021November 2023Abandon2610NoNo
17487590SOYBEAN VARIETY 01083701September 2021April 2023Allow1800NoNo
17482357SOYBEAN CULTIVAR 06110608September 2021June 2023Allow2110YesNo
17482388SOYBEAN CULTIVAR 07090548September 2021March 2023Allow1800NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KEOGH, MATTHEW R.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
3
(75.0%)
Examiner Reversed
1
(25.0%)
Reversal Percentile
36.6%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
14
Allowed After Appeal Filing
4
(28.6%)
Not Allowed After Appeal Filing
10
(71.4%)
Filing Benefit Percentile
38.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 28.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner KEOGH, MATTHEW R - Prosecution Strategy Guide

Executive Summary

Examiner KEOGH, MATTHEW R works in Art Unit 1663 and has examined 715 patent applications in our dataset. With an allowance rate of 83.1%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 24 months.

Allowance Patterns

Examiner KEOGH, MATTHEW R's allowance rate of 83.1% places them in the 51% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by KEOGH, MATTHEW R receive 1.58 office actions before reaching final disposition. This places the examiner in the 41% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by KEOGH, MATTHEW R is 24 months. This places the examiner in the 70% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +7.8% benefit to allowance rate for applications examined by KEOGH, MATTHEW R. This interview benefit is in the 39% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 19.8% of applications are subsequently allowed. This success rate is in the 13% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 33.6% of cases where such amendments are filed. This entry rate is in the 42% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 63.6% of appeals filed. This is in the 37% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 75.3% are granted (fully or in part). This grant rate is in the 90% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.1% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

    Relevant MPEP Sections for Prosecution Strategy

    • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
    • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
    • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
    • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
    • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
    • MPEP § 1214.07: Reopening prosecution after appeal

    Important Disclaimer

    Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

    No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

    Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

    Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.